Bristol-Myers Squibb
BMY
#189
Rank
A$159.86 B
Marketcap
A$78.53
Share price
0.38%
Change (1 day)
-12.37%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): A$4.61

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$4.47. In 2024 the company made an earnings per share (EPS) of A-$6.66 a decrease over its 2023 EPS that were of A$5.84.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$4.61-169.26%
2024A-$6.66-213.92%
2023A$5.8430.2%
2022A$4.49-6.04%
2021A$4.78-179.29%
2020A-$6.02-281.37%
2019A$3.32-27.21%
2018A$4.56
2016A$4.02175.26%
2015A$1.46-19.83%
2014A$1.82-22.44%
2013A$2.3534.48%
2012A$1.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$2.59-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$11.43 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$30.90 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.08 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$5.58 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
A$4.57 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$15.72 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.04-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$19.62 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$16.55 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA